Impact Factor: 4.626 (Source: 2015 ISI) Journal Ranking:  4/59 Chemistry, Medicinal; 31/253 Pharmacology & Pharmacy. Source: Thomson Reuters Journal Citation Reports 2015 Circulation: The Publisher does not disclose the circulation. Aims of the journal: Expert Opinion on Therapeutic Patents is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on recent pharmaceutical patent claims, providing expert opinion the scope for future development, in the context of the scientific literature. Readership: The audience consists of scientists, managers and decision-makers in the pharmaceutical industry and others closely involved in R&D. Content: The Editors welcome: Reviews covering recent patent claims on compounds or applications with therapeutic potential, including biotherapeutics and small-molecule agents with specific molecular targets; and patenting trends in a particular therapeutic area Patent Evaluations examining the aims and chemical and biological claims of individual patents Perspectives on issues relating to intellectual property Manuscript submission: Instructions for authors can be viewed here Online submission here

Impact Factor: 4.798 (Source: Thomson Reuters Journal Citation Reports 2015) Journal Ranking: 28/253 Pharmacology & Pharmacy (Source: Thomson Reuters Journal Citation Reports 2015) Circulation: A figure is not disclosed. Distribution: It is available via subscription.  Aims of the Journal: The journal evaluates molecules, signal pathways, receptors and other therapeutic targets and their potential as candidates for drug development. Articles in this journal focus on the molecular level and should not include clinical information on specific drugs. Expert Opinion on Therapeutic Targets is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on novel molecular targets, with the aim of providing expert opinion on the scope for future drug development and the impact on drug discovery.  Editors welcome reviews covering novel disease targets at the molecular level and their implications for future drug development and original research papers reporting results of target selection and validation studies and basic mechanism of action studies for investigative and marketed drugs. Readership: Scientists, managers and decision makers in the pharmaceutical industry, academic researchers working in the field of molecular medicine and others closely involved in R&D. Manuscript Submission: Information for contributors can be found here and here. Other information: There is no generic email address. The Editorial Board can be found here. 

Impact factor: 3.542 (Thomson Reuters, Journal Citation Reports) Journal Ranking: 59/253 Pharmacology and Pharmacy (Source: Publisher) Circulation: The publisher does not disclose the circulation. Aims of the Journal: Expert Review of Anti-infective Therapy aims to provide reviews on therapeutics and diagnostics in the treatment of infectious disease. Coverage includes antibiotics, drug resistance, drug therapy, infectious disease medicine, antibacterial, antimicrobial, antifungal and antiviral approaches, and diagnostic tests. Content: The Expert Review format endeavours to provide an overview of current thinking in a key area of anti-infective research or clinical practice. It includes the following sections: Expert Commentary - a personal view on the most effective or promising strategies Five-year view - a perspective of future prospects within a realistic time scale Key issues - a summary cutting to the author's most critical points Manuscript Submission: Unsolicited manuscripts are accepted for publication in the journal; please contact the Commissioning Editor with a brief proposal and article outline. All articles are subject to rigorous peer-review. Author guidelines can be viewed here. Online manuscript submission can be found here. Ad Rates: Further information on ad rates can be found here.

Impact Factor: 2.094 (Source: 2015 Thomson Reuters, Journal Citation Reports). Journal Ranking: 150/213 (Oncology) - (Source: Publisher) Circulation: The Publisher does not disclose the circulation. Aims of the Journal: Expert Review of Anticancer Therapy provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches. Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. Content: Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections: - Expert Commentary: a personal view on the most effective or promising strategies - Five-year view: a clear perspective of future prospects within a realistic time-scale - Key issues: an executive summary cutting to the author's most critical points Readership: The journal is aimed at doctors and Health professionals working in Oncology mainly. Manuscript Submission: Articles published in the journal are commissioned by the Editor in collaboration with the Editorial Advisory Board. All articles are subject to rigorous peer-review. Author guidelines can be found here. Online manuscripts submission can be found here. Ad Rates: Advertising information can be found here.

Impact Factor: 2.596 (Source: Publisher) Journal Ranking: 83/150 (Immunology) (Source: 2015 Journal Citation Reports, Thomson Reuters 2016) Circulation: The figure is not currently disclosed. Frequency: Published 12 times a year. Aims of the journal: Expert Review of Clinical Immunology aims to identify the most important and topical review themes and the corresponding expert(s) most appropriate to provide commentary and analysis. All articles are subject to rigorous peer-review, and the finished reviews provide an essential contribution to decision-making in clinical immunology. Content: Articles focus on the following key areas: Therapeutic overviews of specific immunologic disorders highlighting optimal therapy and prospects for new medicines Performance and benefits of newly approved therapeutic agents New diagnostic approaches Screening and patient stratification Pharmacoeconomic studies New therapeutic indications for existing therapies Adverse effects, occurrence and reduction Prospects for medicines in late-stage trials approaching regulatory approval Novel treatment strategies Epidemiological studies Commentary and comparison of treatment guidelines Topics include infection and immunity, inflammation, host defense mechanisms, congenital and acquired immunodeficiencies, anaphylaxis and allergy, systemic immune diseases, organ-specific inflammatory diseases, transplantation immunology, endocrinology and diabetes, cancer immunology, neuroimmunology and hematological diseases. Editorial contacts: See the full list of editorial contacts here Manuscript Submission: See author guidelines here Access online submission portal here Other information: To discuss advertising & sponsorship needs, contact Per Sonnerfeldt at per.sonnerfeldt@informa.com.

Impact factor: 2.488 (2015) Circulation: The Publisher does not disclose the circulation Frequency: Bi-monthly Aims of the journal: Clinical pharmacology aims to provide an essential role in integrating the expertise of all of the specialists and players who are active in meeting such challenges in modern biomedical practice. Expert Review of Clinical Pharmacology provides a forum for informed debate and critical analysis of all aspects of safety, tolerability, efficacy and therapeutic applications, in addition to covering toxicity issues, adverse reactions, pharmacoeconomics and societal issues. Content: Coverage includes: ADME studies and PK/PD modeling Novel clinical trial design and conduct Toxicity and carcinogenesis Adverse effects/reactions, drug–drug and drug–disease interactions Pharmacogenetics, genomics and the incorporation of new biomarkers in drug development and clinical practice Translational medicine Pharmacoepidemiology, risk management and pharmacovigilance Pharmacotherapy in specific patient groups, such as children, women, the immunocompromised Pharmacology and ethnicity Impact on quality of life and pharmacoeconomic issues Regulation of drug development and marketing Epidemiology and biostatistics Readership: The journal is aimed at clinical and pharmaceutical researchers, drug development specialists, physicians and other healthcare professionals with the key information they need to assist in the progress of pharmacological therapy. Manuscript submission: Contact the Commissioning Editor with a brief proposal and article outline. All articles are subject to rigorous peer-review. Instructions for authors can be viewed here Online manuscripts submission can be found here For authors preparing Drug Profiles or Clinical Trial Commentaries, please contact Mary Yianni for article-specific guidelines.

Impact factor: 0.49 (Source: SJR) Circulation: The Publisher does not disclose the circulation Frequency: Published 6 times a year. Aims of the journal: Expert Review of Endocrinology and Metabolism, provides extensive coverage of state-of-the-art research and clinical advancements in the field of endocrine control and metabolism, with a focus on screening, prevention, diagnostics, existing and novel therapeutics, as well as related molecular genetics, pathophysiology and epidemiology. It aims to serve all professionals within this speciality, encompassing topics in clinical diseases such as diabetes, osteoporosis, thyroid disease, adrenal insufficiency and pituitary tumors, as well as disorders associated with growth, reproduction, weight management and hormone-regulated gene expression. Content: Comprehensive coverage is augmented by: Expert commentary - a personal opinion on the most effective or promising strategies Five-year view - a clear perspective of future prospects within a realistic timescale Key issues - an executive summary cutting to the author's most critical points Editorial Contacts: Please see the list of editorial contacts here.   Manuscript submission: Unsolicited manuscripts are accepted for publication in the journal; please contact the Commissioning Editor with a brief proposal and article outline. All articles are subject to rigorous peer-review. Author guidelines can be found here. Online manuscripts submission can be found here.

Impact Factor: 2.546 Journal Ranking: 33/74 (Gastroenterology & Hepatology) Circulation: The Publisher does not disclose the circulation Frequency: Bi-monthly Aims of the journal: Expert Review of Gastroenterology & Hepatology provides comprehensive coverage of state-of-the-art research and clinical advancements in the field as they occur. The journal focuses on the latest advances in our pathological, biochemical and physiological understanding of the diseases affecting the gastrointestinal tract and liver, in addition to up-to-the-minute developments in strategies for prevention, diagnosis and intervention. Content: Article coverage includes the following key areas: Latest advances in pathological, biochemical and physiological understanding of the diseases of the digestive system and its associated organs Developments in investigative strategies; such as radiology, endoscopy, cholangiopancreatography, colonoscopy and liver biopsy Advances in molecular diagnosis and biomarker research Recent developments in pharmacological approaches and emerging therapeutics Drug safety Disease-specific reviews, including coverage of digestive cancers, hepatitis infections, liver cirrhosis, inflammatory bowel disease, functional gastrointestinal disorder, and biliary and gall bladder disease Optimal management of pediatric digestive diseases, with regard to diagnosis and issues, such as absorption, nutrition and growth Psychosocial aspects Pharmacoeconomics and outcomes research, supplemented by cost–benefit analysis Readership: The journal is aimed at doctors and health professionals working in the Gastroenterology & Hepatology area Manuscript submission: Unsolicited manuscripts are accepted for publication in the journal; please contact the Commissioning Editor with a brief proposal and article outline. All articles are subject to rigorous peer-review. Author guidelines can be found here Online manuscripts submission can be found here

Impact Factor: 2.439 Journal Ranking: 40/70 in Hematology (Thomson Reuters Journal Citation Reports 2015) Circulation: The Publisher does not disclose the circulation Aims of the journal: Expert Review of Hematology provides commentary and analysis to elucidate best clinical practice in hematology and to translate advances in research - in areas such as immunology, stem cell research, and cell and gene therapy – into the clinical context. Content: Areas covered include: Acute leukemias Anemias Bleeding disorders Bone marrow and hematopoietic stem cell transplantation Cellular disorders Chronic leukemias Disorders of iron metabolism Hodgkins disease. Infection in hematology Immunodeficiency syndromes Autoimmune diseases Marrow failure syndromes Multiple myeloma and amyloidosis Neutropenia Non-Hodgkin lymphomas Pediatric hematology Platelet disorders Thrombosis and hemostasis Transfusion medicine Manuscript submission: Unsolicited manuscripts are accepted for publication in the journal; please contact the Commissioning Editor with a brief proposal and article outline. All articles are subject to rigorous peer-review. Author guidelines can be found here Online manuscripts submission can be found here

Impact Factor: 1.796 Journal Ranking: 40/76 (source: Engineering, Biomedical) Circulation: The Publisher does not disclose the circulation Frequency: Monthly Aims of the journal: Expert Review of Medical Devices provides commentary, analysis and debate for all professionals involved in research, development, testing and clinical use of devices. In addition to the Review program, each issue also features Medical Device Profiles - objective assessments of specific devices in development or clinical use to help inform clinical practice. Content: Comprehensive coverage by each author in a key area of research or clinical practice is augmented by the following sections: Expert Commentary - a personal view on the most effective or promising strategies Five-year view - a clear perspective of future prospects within a realistic timescale Key issues - an executive summary cutting to the author's most critical point Readership: The journal serves the device research community by providing a comprehensive body of high-quality information from leading experts, all subject to rigorous peer-review. Manuscript submission: Unsolicited manuscripts are accepted for publication in the journal; please contact the Commissioning Editor with a brief proposal and article outline. All articles are subject to rigorous peer-review. Ad Rates: Advertising information can be found here Other information: Author guidelines can be found here. Online manuscripts submission can be found here.